How can we manage the cardiac toxicity of immune checkpoint inhibitors?-Reference-Cited by-同舟云学术

How can we manage the cardiac toxicity of immune checkpoint inhibitors?

Published:2021-04-01 Issue: Volume: Page:1-10
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Poto Remo¹,Marone Giancarlo²³,Pirozzi Flora¹,Galdiero Maria Rosaria¹⁴⁵⁶,Cuomo Alessandra¹^ORCID,Formisano Luigi⁷⁸,Bianco Roberto⁷⁸,Della Corte Carminia Maria⁹,Morgillo Floriana⁹,Napolitano Stefania⁹,Troiani Teresa⁹,Tocchetti Carlo G¹⁴⁵⁸¹⁰^ORCID,Mercurio Valentina¹,Varricchi Gilda¹⁴⁵⁶

Affiliation:

1. Department of Translational Medical Sciences, Federico II University, Naples, Italy

2. Department of Public Health, Section of Hygiene, University of Naples Federico II, Naples, Italy

3. Monaldi Hospital Pharmacy, Naples, Italy

4. Center for Basic and Clinical Immunology Research (CISI), Federico II University, Naples, Italy

5. WAO Center of Excellence, Naples, Italy

6. Institute of Experimental Endocrinology and Oncology “G. Salvatore” (IEOS), National Research Council (CNR), Naples, Italy

7. Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy

8. Interdepartmental Center of Clinical and Translational Research (CIRCET), Federico II University, Naples, Italy

9. Department of Precision Medicine, Luigi Vanvitelli University of Campania, Naples, Italy

10. Interdepartmental Hypertension Research Center (CIRIAPA), Federico II University, Naples, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2021.1906860

Reference106 articles.

1. Cancer immunotherapy using checkpoint blockade

2. Neoadjuvant checkpoint blockade for cancer immunotherapy

3. New insight in endocrine-related adverse events associated to immune checkpoint blockade

4. Tumour-intrinsic resistance to immune checkpoint blockade

5. Dissecting the mechanisms of immune checkpoint therapy

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mast cells: a novel therapeutic avenue for cardiovascular diseases?;Cardiovascular Research;2024-04-17

2. Clinical characteristics, diagnosis and management of nivolumab-induced myocarditis;Investigational New Drugs;2024-01-23

3. Acute heart failure: mechanisms and pre-clinical models—a Scientific Statement of the ESC Working Group on Myocardial Function;Cardiovascular Research;2023-10

4. Immune Checkpoint Inhibitors-Related Myocarditis: A Review of Reported Clinical Cases;Diagnostics;2023-03-25

5. Cardiotoxicity Induced by Immune Checkpoint Inhibitors: What a Cardio-Oncology Team Should Know and Do;Cancers;2022-11-02